Search Videos and More
News
Dana-Farber Research News 04.01.2026
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from March 1 - 15.
News
Dana-Farber Chair of Pathology, Dr. Kathleen Burns, Elected as Fellow of the American Association for the Advancement of Science
Dr. Kathleen Burns, Chair of Pathology at Dana-Farber Cancer Institute, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is a distinguished lifetime honor bestowed upon AAAS members by their peers.
News
Dana-Farber Team Develops Open-Access Predictive Tool to Improve Monitoring of Smoldering Multiple Myeloma
The tool, called PANGEA-SMM, outperforms existing predictive tools by more accurately determining when smoldering multiple myeloma is progressing and requires treatment. The free online tool can be used immediately to monitor patients.
Symposium
Breast Cancer Breakthroughs: SABCS 2025 Highlights
Experts in Dana-Farber’s Breast Oncology Center discuss highlights in breast cancer research innovation presented at SABCS 2025 in San Antonio, Texas, including what the data means, how it can be used in clinic, and what’s next in the field of breast cancer research.
News
Dana-Farber Research News 03.15.2026
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from February 16 - 28.
News
Dana Farber/Boston Children’s Researchers Uncover Distinct Tumor “neighborhoods” with Each Cell Subtype Playing a Specific Role, in Aggressive Childhood Brain Cancer
Their detailed blueprint of tumor cell diversity could guide more precise, targeted treatments for supratentorial ependymomas
News
When Small Cell Lung Cancer Hides from Immune Cells, Blood Vessels May Hold the Key
Researchers at Dana-Farber Cancer Institute have uncovered why small cell lung cancer (SCLC) can stay largely out of reach of the immune system, even when the cancer cells themselves are vulnerable to immune attack.
News
The Gene Fixer
For five decades, Stuart Orkin has harnessed new genetic tools to transform care for blood disorders – helping make sickle cell and beta thalassemia curable.
News
Dana-Farber Researchers Join Global Cancer Grand Challenges Team Taking on the Dark Proteome
A global, interdisciplinary team of researchers including Dana-Farber’s Cathy Wu, MD, and William Freed-Pastor, MD, PhD, have been selected to receive a Cancer Grand Challenges award of up to $25m over five years to tackle the dark proteome challenge.
News
Dana-Farber Research Uncovers Approach to Activating the Immune System Against Metastatic Breast Cancer
Cancer spreads, or metastasizes, when tumor cells shed from a primary solid tumor, for example in the breast, and embed in other organs, such as the lung, liver, and brain, and begin to grow.
Symposium
Our Ambulatory Cell Therapies Clinic
Our growing outpatient cell therapies program enables many patients to receive stem cell transplant and CAR T-cell therapies without a lengthy hospital admission. Through this program, patients receive the same high-quality, comprehensive care – conditioning chemotherapy, cell infusion, and follow-up monitoring – in our Ambulatory Cell Therapies Clinic and return home or to nearby accommodations each day during their treatment period.
News
Dana-Farber Research News 03.01.2026
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from February 1 - 15.